Evolus Net Income vs. Current Valuation
| EOLS Stock | USD 4.50 0.00 0.00% |
Net Loss | First Reported 2015-12-31 | Previous Quarter -17.1 M | Current Value -15.7 M | Quarterly Volatility 17.7 M |
| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Gross Profit Margin | 0.74 | 0.79 |
|
|
For Evolus profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Evolus to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Evolus Inc utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Evolus's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Evolus Inc over time as well as its relative position and ranking within its peers.
Check out Investing Opportunities. Is there potential for Pharmaceuticals market expansion? Will Evolus introduce new products? Factors like these will boost the valuation of Evolus. Projected growth potential of Evolus fundamentally drives upward valuation adjustments. Understanding fair value requires weighing current performance against future potential. All the valuation information about Evolus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.90) | Revenue Per Share | Quarterly Revenue Growth 0.129 | Return On Assets | Return On Equity |
The market value of Evolus Inc is measured differently than its book value, which is the value of Evolus that is recorded on the company's balance sheet. Investors also form their own opinion of Evolus' value that differs from its market value or its book value, called intrinsic value, which is Evolus' true underlying value. Analysts utilize numerous techniques to assess fundamental value, seeking to purchase shares when trading prices fall beneath estimated intrinsic worth. Because Evolus' market value can be influenced by many factors that don't directly affect Evolus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Evolus' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Evolus should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Evolus' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Evolus Inc Current Valuation vs. Net Income Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Evolus's current stock value. Our valuation model uses many indicators to compare Evolus value to that of its competitors to determine the firm's financial worth. Evolus Inc is rated # 4 in net income category among its peers. It is rated # 2 in current valuation category among its peers . At this time, Evolus' Net Loss is comparatively stable compared to the past year. Comparative valuation analysis is a catch-all technique that is used if you cannot value Evolus by discounting back its dividends or cash flows. It compares the stock's price multiples to nearest competition to determine if the stock is relatively undervalued or overvalued.Evolus Current Valuation vs. Net Income
Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Evolus |
| = | (50.42 M) |
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Evolus |
| = | 496.81 M |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Evolus Current Valuation vs Competition
Evolus Inc is rated # 2 in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is currently estimated at about 3.58 Billion. Evolus retains roughly 496.81 Million in current valuation claiming about 14% of equities under Health Care industry.
Evolus Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Evolus, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Evolus will eventually generate negative long term returns. The profitability progress is the general direction of Evolus' change in net profit over the period of time. It can combine multiple indicators of Evolus, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | -814.5 K | -773.8 K | |
| Operating Income | -31 M | -32.5 M | |
| Net Loss | -45.4 M | -47.6 M | |
| Income Before Tax | -44.8 M | -47 M | |
| Total Other Income Expense Net | -13.8 M | -13.1 M | |
| Net Loss | -67 M | -70.3 M | |
| Net Loss | -45.4 M | -47.6 M | |
| Income Tax Expense | 763.6 K | 801.8 K | |
| Net Interest Income | -13.9 M | -13.2 M | |
| Interest Income | 3.8 M | 3.9 M | |
| Non Operating Income Net Other | 126.5 K | 132.8 K | |
| Change To Netincome | 20.9 M | 14.8 M | |
| Net Loss | (0.73) | (0.77) | |
| Income Quality | 0.41 | 0.39 | |
| Net Income Per E B T | 0.91 | 0.74 |
Evolus Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Evolus. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Evolus position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Evolus' important profitability drivers and their relationship over time.
Evolus Earnings Estimation Breakdown
The calculation of Evolus' earning per share is based on the data from the past 12 consecutive months, used for reporting the company's financial figures. The next projected EPS of Evolus is estimated to be -0.01625 with the future projection ranging from a low of -0.0425 to a high of 0.01. Please be aware that this consensus of annual earnings estimates for Evolus Inc is based on EPS before non-recurring items and includes expenses related to employee stock options.Last Reported EPS
-0.04 Lowest | Expected EPS | 0.01 Highest |
Evolus Earnings Projection Consensus
Suppose the current estimates of Evolus' value are higher than the current market price of the Evolus stock. In this case, investors may conclude that Evolus is overpriced and will exhibit bullish sentiment. On the other hand, if the present value is lower than the stock price, analysts may conclude that the market undervalues the equity. These scenarios may suggest that the market is not as efficient as it should be at the estimation time, and Evolus' stock will quickly adjusts to the new information provided by the consensus estimate.
| Number of Analysts | Historical Accuracy | Last Reported EPS | Estimated EPS for 31st of December 2026 | Current EPS (TTM) | |
| 7 | 67.42% | 0.0 | -0.01625 | -0.9 |
Evolus Earnings per Share Projection vs Actual
Actual Earning per Share of Evolus refers to what the company shows during its earnings calls or quarterly reports. The Expected EPS is what analysts covering Evolus Inc predict the company's earnings will be in the future. The higher the earnings per share of Evolus, the better is its profitability. While calculating the Earning per Share, we use the weighted ratio, as the number of shares outstanding can change over time.Evolus Estimated Months Earnings per Share
For an investor who is primarily interested in generating an income out of investing in entities such as Evolus, the EPS ratio can tell if the company is intending to increase its current dividend. Although EPS is an essential tool for investors, it should not be used in isolation. EPS of Evolus should always be considered in relation to other companies to make a more educated investment decision.Evolus Quarterly Analyst Estimates and Surprise Metrics
Earnings surprises can significantly impact Evolus' stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
| Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
|---|---|---|---|---|---|---|---|
null | null | null | null | null | 0 | ||
null | null | null | null | null | 0 | ||
2025-11-05 | 2025-09-30 | -0.15 | -0.24 | -0.09 | 60 | ||
2025-08-05 | 2025-06-30 | -0.1 | -0.27 | -0.17 | 170 | ||
2025-05-05 | 2025-03-31 | -0.1 | -0.17 | -0.07 | 70 | ||
2025-03-04 | 2024-12-31 | 0.0223 | 0.0139 | -0.0084 | 37 | ||
2024-11-06 | 2024-09-30 | -0.1 | -0.16 | -0.06 | 60 | ||
2024-07-31 | 2024-06-30 | -0.05 | -0.04 | 0.01 | 20 | ||
2024-05-07 | 2024-03-31 | -0.1 | -0.09 | 0.01 | 10 | ||
2024-03-07 | 2023-12-31 | -0.07 | -0.12 | -0.05 | 71 | ||
2023-11-07 | 2023-09-30 | -0.17 | -0.16 | 0.01 | 5 | ||
2023-08-02 | 2023-06-30 | -0.19 | -0.19 | 0.0 | 0 | ||
2023-05-09 | 2023-03-31 | -0.15 | -0.15 | 0.0 | 0 | ||
2023-03-08 | 2022-12-31 | -0.15 | -0.14 | 0.01 | 6 | ||
2022-11-08 | 2022-09-30 | -0.28 | -0.28 | 0.0 | 0 | ||
2022-08-02 | 2022-06-30 | -0.24 | -0.28 | -0.04 | 16 | ||
2022-05-10 | 2022-03-31 | -0.33 | -0.22 | 0.11 | 33 | ||
2022-03-03 | 2021-12-31 | -0.19 | -0.22 | -0.03 | 15 | ||
2021-11-02 | 2021-09-30 | -0.27 | -0.27 | 0.0 | 0 | ||
2021-08-04 | 2021-06-30 | -0.24 | -0.19 | 0.05 | 20 | ||
2021-05-12 | 2021-03-31 | -0.43 | -0.2 | 0.23 | 53 | ||
2021-03-24 | 2020-12-31 | -0.24 | -0.44 | -0.2 | 83 | ||
2020-10-29 | 2020-09-30 | -0.38 | -0.27 | 0.11 | 28 | ||
2020-08-10 | 2020-06-30 | -0.73 | -0.43 | 0.3 | 41 | ||
2020-05-11 | 2020-03-31 | -0.62 | -0.75 | -0.13 | 20 | ||
2020-02-25 | 2019-12-31 | -0.8 | -0.47 | 0.33 | 41 | ||
2019-11-04 | 2019-09-30 | -1.16 | -0.78 | 0.38 | 32 | ||
2019-08-12 | 2019-06-30 | -0.88 | -1.2 | -0.32 | 36 | ||
2019-04-30 | 2019-03-31 | -0.74 | -0.4 | 0.34 | 45 | ||
2019-03-18 | 2018-12-31 | -0.55 | -0.46 | 0.09 | 16 | ||
2018-11-05 | 2018-09-30 | -0.44 | -0.48 | -0.04 | 9 | ||
2018-08-02 | 2018-06-30 | -0.29 | -0.34 | -0.05 | 17 | ||
2018-05-10 | 2018-03-31 | -0.24 | -0.3 | -0.06 | 25 | ||
2018-03-29 | 2017-12-31 | -0.3 | -0.28 | 0.02 | 6 | ||
2017-11-29 | 2017-09-30 | 0 | -0.26 | -0.26 | 0 | ||
2017-08-28 | 2017-06-30 | 0 | -0.27 | -0.27 | 0 | ||
2017-05-04 | 2017-03-31 | 0 | -0.17 | -0.17 | 0 |
Use Evolus in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Evolus position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Evolus will appreciate offsetting losses from the drop in the long position's value.Evolus Pair Trading
Evolus Inc Pair Trading Analysis
The ability to find closely correlated positions to Evolus could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evolus when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evolus - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evolus Inc to buy it.
The correlation of Evolus is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Evolus moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Evolus Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Evolus can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Evolus position
In addition to having Evolus in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Energy ETFs Thematic Idea Now
Energy ETFs
ETF themes focus on helping investors to gain exposure to a broad range of assets, diversify, and lower overall costs. The Energy ETFs theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Energy ETFs Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Evolus Stock Analysis
When running Evolus' price analysis, check to measure Evolus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Evolus is operating at the current time. Most of Evolus' value examination focuses on studying past and present price action to predict the probability of Evolus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Evolus' price. Additionally, you may evaluate how the addition of Evolus to your portfolios can decrease your overall portfolio volatility.